Overview
Salaries
Products
People
Growth
Offices
Financials

Overview

We aim to give patients the opportunity to live longer and better. Learn more about our lead drug, elraglusib.

People

Daniel Schmitt
Executive Officer, Director
Andrew Mazar
Executive Officer
Paul Lytle
Executive Officer
Aaron Fletcher
Director
Leslie Kreis Jr.
Director
Aaron Glenn Fletcher
Director
Alex Andrianopoulos
Director
Neil Bajpayee
Director
Pascal Krotee
Director
Dan Zabrowski
Director
Todd Thomson
Director
Daniel Zabrowski
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Fort Worth United States
HQ
CONTACT US
200-500 est. staff
1751 River Run, Suite 400, Fort Worth, TX 76107
company site

Financials

Total raised
$102.9M
Latest round
Venture - Series Unknown
Funding rounds
11
Funding rounds
Round Announced Amount
Venture - Series Unknown 2025 $4.7M Details
Debt Financing 2024 $3M Details
Venture - Series Unknown 2022 $19.3M Details
Venture - Series Unknown 2022 $19.3M Details
Venture - Series Unknown 2020 $14.5M Details
Venture - Series Unknown 2019 $6.5M Details
Venture - Series Unknown 2019 $6.5M Details
Venture - Series Unknown 2019 $21.9M Details
Debt Financing 2018 $4M Details
Venture - Series Unknown 2017 $3M Details
Debt Financing 2017 $150k Details